Larvol Delta - A-Study-of-the-Drug-Letermovir-as-Prevention-of-Cytomegalovirus-Infection-After-Stem-Cell-Transplant-in-Pediatric-Patients

Prevymis (letermovir) - Merck (MSD)

http://clinicaltrials.gov/ct2/show/NCT05711667

Nov 7, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next